Bone Health Technologies (BHT) has opened pre-orders for Osteoboost, the first FDA-cleared wearable medical device designed to treat osteopenia, a condition affecting millions at risk of fractures.The device is a non-invasive, non-drug treatment option for postmenopausal women with low bone density. Priced at $995 during the pre-order phase (compared to a $1,500 list price), Osteoboost is expected to ship in 60–90 days.Osteoboost uses precision vibration therapy to target the hips […]